[HTML][HTML] The immune response to SARS-CoV-2 and COVID-19 immunopathology–current perspectives
JL Boechat, I Chora, A Morais, L Delgado - Pulmonology, 2021 - Elsevier
SARS-CoV-2 is a new beta coronavirus, similar to SARS-CoV-1, that emerged at the end of
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
2019 in the Hubei province of China. It is responsible for coronavirus disease 2019 (COVID …
[PDF][PDF] Immunology of COVID-19: current state of the science
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
[HTML][HTML] COVID-19 immunobiology: lessons learned, new questions arise
A Kaklamanos, K Belogiannis, P Skendros… - Frontiers in …, 2021 - frontiersin.org
There is strong evidence that COVID-19 pathophysiology is mainly driven by a
spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning from …
spatiotemporal immune deregulation. Both its phenotypic heterogeneity, spanning from …
[HTML][HTML] Immune response, inflammation, and the clinical spectrum of COVID-19
LF García - Frontiers in immunology, 2020 - frontiersin.org
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly
extended to become a global sanitary and economic emergency. Its etiological agent is the …
extended to become a global sanitary and economic emergency. Its etiological agent is the …
COVID‐19 immunopathology: from acute diseases to chronic sequelae
The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …
as a primary affected organ, which is also a critical site of immune cell activation by severe …
COVID-19: Immunology and treatment options
S Felsenstein, JA Herbert, PS McNamara… - Clinical …, 2020 - Elsevier
The novel coronavirus SARS-CoV2 causes COVID-19, a pandemic threatening millions. As
protective immunity does not exist in humans and the virus is capable of escaping innate …
protective immunity does not exist in humans and the virus is capable of escaping innate …
[HTML][HTML] The immune response and immunopathology of COVID-19
Coronaviruses were first discovered in the 1960s and are named due to their crown-like
shape. Sometimes, but not often, a coronavirus can infect both animals and humans. An …
shape. Sometimes, but not often, a coronavirus can infect both animals and humans. An …
The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic
The COVID‐19 pandemic has represented an unprecedented challenge for the humanity,
and scientists around the world provided a huge effort to elucidate critical aspects in the fight …
and scientists around the world provided a huge effort to elucidate critical aspects in the fight …
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses—are we our own worst enemy?
Human coronaviruses cause a wide spectrum of disease, ranging from mild common colds
to acute respiratory distress syndrome and death. Three highly pathogenic human …
to acute respiratory distress syndrome and death. Three highly pathogenic human …
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
LM Khosroshahi, M Rokni, T Mokhtari… - International …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) infection which is caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …
respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a “public health emergency of …